FDA approves hydroxychloroquine as emergency coronavirus treatment

The 'known and potential' benefits outweigh the 'known and potential risks', says the regulator

The US drugs regulator has controversially approved the anti-malarial drugs hydroxychloroquine and chloroquine to treat seriously ill patients with COVID-19.